BR112015030989A2 - composição farmacêutica, e, uso de uma composição - Google Patents

composição farmacêutica, e, uso de uma composição

Info

Publication number
BR112015030989A2
BR112015030989A2 BR112015030989A BR112015030989A BR112015030989A2 BR 112015030989 A2 BR112015030989 A2 BR 112015030989A2 BR 112015030989 A BR112015030989 A BR 112015030989A BR 112015030989 A BR112015030989 A BR 112015030989A BR 112015030989 A2 BR112015030989 A2 BR 112015030989A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BR112015030989A
Other languages
English (en)
Inventor
Christina Schrier Carla
Adema Gosse
Brok Den; Martijn
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BR112015030989A2 publication Critical patent/BR112015030989A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR112015030989A 2013-06-14 2014-06-13 composição farmacêutica, e, uso de uma composição BR112015030989A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13172144 2013-06-14
PCT/EP2014/062308 WO2014198862A1 (en) 2013-06-14 2014-06-13 Pharmaceutical compositions comprising a gpg oligodeoxynucleotide and cyclic di-gmp

Publications (1)

Publication Number Publication Date
BR112015030989A2 true BR112015030989A2 (pt) 2019-09-24

Family

ID=48628330

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015030989A BR112015030989A2 (pt) 2013-06-14 2014-06-13 composição farmacêutica, e, uso de uma composição

Country Status (9)

Country Link
US (1) US20160136197A1 (pt)
EP (1) EP3007703A1 (pt)
JP (1) JP2016526532A (pt)
CN (1) CN105263502A (pt)
AU (1) AU2014280133B2 (pt)
BR (1) BR112015030989A2 (pt)
CA (1) CA2914728A1 (pt)
RU (1) RU2016100235A (pt)
WO (1) WO2014198862A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11058758B2 (en) * 2014-11-20 2021-07-13 National Institutes Of Biomedical Innovation, Health And Nutrition TH1-inducing adjuvant comprising combination of different nucleic acid adjuvants, and use of same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
US6406705B1 (en) * 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
US9226959B2 (en) * 2008-01-31 2016-01-05 Curevac Ag Nucleic acids comprising formula (NuGlXmGnNv)a and derivatives thereof as immunostimulating agent/adjuvant
CN102199183B (zh) * 2010-03-26 2013-12-18 北京大学 环二鸟苷酸及其类似物和制备方法
JP5930967B2 (ja) * 2010-09-08 2016-06-08 学校法人 埼玉医科大学 Ｃ型肝炎ウイルスリポソームワクチン
EP2471926A3 (en) 2010-12-30 2012-07-11 Intervet International BV Immunostimulatory oligodeoxynucleotides
CN103547674A (zh) 2011-05-26 2014-01-29 英特维特国际股份有限公司 免疫刺激性寡脱氧核苷酸
TR201808393T4 (tr) 2011-05-26 2018-07-23 Intervet Int Bv İmmünostimülatör oligodeoksinükleotitler.
CN104507538B (zh) * 2012-06-08 2018-04-06 艾杜罗生物科技公司 癌症免疫疗法的组合物和方法

Also Published As

Publication number Publication date
CA2914728A1 (en) 2014-12-18
JP2016526532A (ja) 2016-09-05
WO2014198862A1 (en) 2014-12-18
AU2014280133B2 (en) 2016-12-15
EP3007703A1 (en) 2016-04-20
AU2014280133A1 (en) 2015-12-24
CN105263502A (zh) 2016-01-20
RU2016100235A (ru) 2017-07-17
US20160136197A1 (en) 2016-05-19

Similar Documents

Publication Publication Date Title
FR21C1059I2 (fr) Compositions pharmaceutiques
BR112016003229A2 (pt) Composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica
DK3030262T3 (da) Kombineret farmaceutisk sammensætning
CR20150380A (es) Compuestos de carbamoilpiridona policíclicos y su uso farmacéutico
BR112016015706A2 (pt) composto, uso do mesmo e composição farmacêutica
BR112015000420A2 (pt) composto, composição farmacêutica, e, uso de um composto
IL243608A0 (en) Substances with antiviral activity, preparations containing them and their uses
BR112014029115A2 (pt) composto, composição farmacêutica, e, uso de um composto ou composição
DK3181128T3 (da) Farmaceutisk nilotinib-sammensætning
BR112015002738A2 (pt) composto , e , composição farmacêutica
BR112014023200A2 (pt) uso de uma composição
DK3043778T3 (da) Farmaceutiske sammensætninger, der indeholder refametinib
DK2897594T3 (da) Farmaceutisk sammensætning
DK3275452T3 (da) Farmaceutisk sammensætning med silibinin
DK2968146T3 (da) Liposomsammensætning med kontrolleret lægemiddelfrigivelse
EP2995308A4 (en) ANTI-HYPOXIC PHARMACEUTICAL COMPOSITION AND USE THEREOF
HK1219691A1 (zh) 醫藥組成物及其用途
BR112014026397A2 (pt) composição e uso de uma composição
FR3001392B1 (fr) Composition dermatologique amelioree
SG11201601477VA (en) Pharmaceutical composition
DK3079667T3 (da) Farmaceutiske doseringsformer
BR112014027027A2 (pt) composição cosmética, método cosmético e uso de uma combinação.
BR112015002646A2 (pt) composto e composição farmacêutica
DK3003401T3 (da) Farmaceutisk præparat
BR112015005500A2 (pt) composto, composição farmacêutica, combinação de um composto, uso de um composto e dispositivo

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.